Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Market

Market Size in USD Billion

CAGR : 17.60%

USD 1.14

2025

USD 4.17

2033

Forecast Period	2025 - 2033
Market Size (Base Year)	USD 1.14 Billion
Market Size (Forecast)	USD 4.17 Billion
CAGR	17.60%
Major Market Players	Data provided in full report

Report on the Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Market is a cradle for all the market-related details right from the finances, regional development to the future market growth rate. It also touches upon the market valuation which comprises of the market size, revenue, and share in order to be acquainted with the current market position on both the regional and global platform. To shed more light on the market growth rate, the report offers information such as recent developments, achievements, obstacles, threats, and market driving factors. The Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Market report provides information validated using few research methodologies and primary or secondary resources.

Data provided by Extent Research. Source: https://www.extentresearch.com/chronic-kidney-disease-mineral-and-bone-disorders-ckd-mbd-market

Key Players:

The dominating players in the Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Market include Akebia, Astellas, Takeda, Vifor, Abbvie, Fresenius, Abbott, Novadiol, Japan Tobacco Company, Daiichi-Sankyo, Shield, Spectrum, OPKO, Ardelyx, Sanofi Genzyme, Amgen, . The market players help understand the supply & demand ratio, consumer preferences, latest manufacturing process, and latest developments. The competitive landscape focuses more on the financial gains and market developments over the forecast period.

Segmentation of the Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Market:

By Product type

Control Hyperphosphatemia, Maintain Blood Calcium Levels, Control PTH Level, Correct Acidosis, Other,

by Application

Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, Drug Stores , Other,

Regional Study:

In the regional analysis, the report clarifies the market regional market attractiveness, industrial developments in specific regions, sales analysis, and other market segmentations. The regions including North America, Europe, Asia Pacific, Latin America, Middle East & Africa, offer excellent socio-economic environment for the Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) industry development. It also confirms the market status on both the regional and global platform.

In this report, the experts have clearly extrapolated facets such as market driving factors, market revenue, share, size, opportunities & challenges, changing market dynamics, key players, dominating regions, economic instabilities, and other competitive factors.

COVID-19 Impact Analysis:

In the Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Market report, the experts have touched upon the pre- and post-COVID-19 impacts. The report elaborates the advantages as well as the disadvantages in terms of finance and market growth attained during this crisis. Despite, a major economic plunge, the Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Market has adopted new strategies and development skills to bounce back. The market has started looking for different funding sources and business approaches to sustain on both the regional and global platform.

Report Scope and Market Segmentation

ATTRIBUTES	Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Market KEY MARKET INSIGHTS
Segments Covered	By Product Type: All Products Type Includes By Application: All Application Type Includes By End User: All End User Type Includes By Distribution Channel: All Distribution Channel Includes
Countries Covered	North America U.S., Canada, Mexico Europe Germany, United Kingdom, France, Italy, Spain, Nordic Countries, Benelux Union, Rest of Europe Asia-Pacific China, India, Japan, New Zealand, South Korea, Australia, Southeast Asia, Rest of Asia Pacific Latin America Brazil, Argentina, Rest of Latin America Middle East & Africa Saudi Arabia, UAE, Egypt, Kuwait, South Africa, Rest of Middle East & Africa
Key Market Players	Leading Tier 1 Corporations Prominent Regional Manufacturers Emerging Market Disruptors Technology Integrators & Suppliers *Complete vendor layout of 15+ major players provided in the final report.
Market Opportunities	Market Size and Growth: Quantifying the total addressable market (TAM) and projected growth rates to assess financial viability. Customer Segmentation: Identifying target audience behaviors, pain points, and specific unfulfilled demands. Competitive Landscape: Analyzing existing competitors' strengths, weaknesses, and market share to pinpoint gaps and opportunities. Industry Trends: Mapping technological, regulatory, and economic shifts that create favorable conditions for market entry. Risk Assessment: Evaluating barriers to entry and operational challenges alongside strategic roadmaps for mitigation.
Value Added Data Infosets	In addition to the insights on market scenarios such as market value, growth rate, segmentation, geographical coverage, and major players, the market reports curated by our expert team also include in-depth expert analysis, geographically represented company-wise production and capacity, network layouts of distributors and partners, detailed and updated price trend analysis and deficit analysis of supply chain and demand.

Meet the Team

Julie

Author

Julie Jayne is a distinguished multidisciplinary strategist and the Head of Research at Extent Research, where she leverages over a decade of comprehensive experience in the global market intelligence industry. Backed by a robust academic foundation that includes a B.Sc. and an MBA, she perfectly...

Priya M

Reviewed By

With over 14 years of dedicated professional expertise in business-to-business (B2B) intelligence, Priya M stands as a distinguished leader in corporate strategy, revenue growth, and advanced data analysis. Her dynamic career is defined by a relentless focus on mitigating business risks and empowering corporate executives...

Learn more about Priya M

BASIC ATTRIBUTES \| KEY MARKET INSIGHTS
Report Title	Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Market
Base Year	2025
Forecast Period	2025 - 2033
Market Size (Base)	USD 1.14 Billion
Projected Size	USD 4.17 Billion
CAGR	17.60%

                            1 Study Coverage
    1.1 Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Product Introduction
    1.2 Market by Type
        1.2.1 Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Market Size Growth Rate by Type, 2017 VS 2021 VS 2035
        1.2.2 Control Hyperphosphatemia
        1.2.3 Maintain Blood Calcium Levels
        1.2.4 Control PTH Level
        1.2.5 Correct Acidosis
        1.2.6 Other
    1.3 Market by Application
        1.3.1 Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Market Size Growth Rate by Application, 2017 VS 2021 VS 2035
        1.3.2 Hospital Pharmacies
        1.3.3 Retail Pharmacies
        1.3.4 Online Pharmacies
        1.3.5 Drug Stores 
        1.3.6 Other
    1.4 Study Objectives
    1.5 Years Considered
2 Executive Summary
    2.1 Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales Estimates and Forecasts 2017-2035
    2.2 Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue Estimates and Forecasts 2017-2035
    2.3 Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue by Region: 2017 VS 2021 VS 2035
    2.4 Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales by Region
        2.4.1 Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales by Region (2017-2022)
        2.4.2 Global Sales Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) by Region (2023-2035)
    2.5 Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue by Region
        2.5.1 Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue by Region (2017-2022)
        2.5.2 Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue by Region (2023-2035)
    2.6 North America
    2.7 Europe
    2.8 Asia-Pacific
    2.9 Latin America
    2.10 Middle East & Africa
3 Competition by Manufacturers
    3.1 Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales by Manufacturers
        3.1.1 Global Top Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Manufacturers by Sales (2017-2022)
        3.1.2 Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales Market Share by Manufacturers (2017-2022)
        3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) in 2021
    3.2 Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue by Manufacturers
        3.2.1 Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue by Manufacturers (2017-2022)
        3.2.2 Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue Market Share by Manufacturers (2017-2022)
        3.2.3 Global Top 10 and Top 5 Companies by Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue in 2021
    3.3 Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales Price by Manufacturers (2017-2022)
    3.4 Analysis of Competitive Landscape
        3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
        3.4.2 Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
        3.4.3 Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Manufacturers Geographical Distribution
    3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
    4.1 Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales by Type
        4.1.1 Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Historical Sales by Type (2017-2022)
        4.1.2 Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Forecasted Sales by Type (2023-2035)
        4.1.3 Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales Market Share by Type (2017-2035)
    4.2 Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue by Type
        4.2.1 Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Historical Revenue by Type (2017-2022)
        4.2.2 Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Forecasted Revenue by Type (2023-2035)
        4.2.3 Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue Market Share by Type (2017-2035)
    4.3 Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Price by Type
        4.3.1 Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Price by Type (2017-2022)
        4.3.2 Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Price Forecast by Type (2023-2035)
5 Market Size by Application
    5.1 Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales by Application
        5.1.1 Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Historical Sales by Application (2017-2022)
        5.1.2 Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Forecasted Sales by Application (2023-2035)
        5.1.3 Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales Market Share by Application (2017-2035)
    5.2 Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue by Application
        5.2.1 Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Historical Revenue by Application (2017-2022)
        5.2.2 Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Forecasted Revenue by Application (2023-2035)
        5.2.3 Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue Market Share by Application (2017-2035)
    5.3 Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Price by Application
        5.3.1 Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Price by Application (2017-2022)
        5.3.2 Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Price Forecast by Application (2023-2035)
6 North America
    6.1 North America Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Market Size by Type
        6.1.1 North America Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales by Type (2017-2035)
        6.1.2 North America Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue by Type (2017-2035)
    6.2 North America Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Market Size by Application
        6.2.1 North America Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales by Application (2017-2035)
        6.2.2 North America Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue by Application (2017-2035)
    6.3 North America Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Market Size by Country
        6.3.1 North America Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales by Country (2017-2035)
        6.3.2 North America Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue by Country (2017-2035)
        6.3.3 U.S.
        6.3.4 Canada
7 Europe
    7.1 Europe Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Market Size by Type
        7.1.1 Europe Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales by Type (2017-2035)
        7.1.2 Europe Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue by Type (2017-2035)
    7.2 Europe Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Market Size by Application
        7.2.1 Europe Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales by Application (2017-2035)
        7.2.2 Europe Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue by Application (2017-2035)
    7.3 Europe Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Market Size by Country
        7.3.1 Europe Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales by Country (2017-2035)
        7.3.2 Europe Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue by Country (2017-2035)
        7.3.3 Germany
        7.3.4 France
        7.3.5 U.K.
        7.3.6 Italy
        7.3.7 Russia
8 Asia Pacific
    8.1 Asia Pacific Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Market Size by Type
        8.1.1 Asia Pacific Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales by Type (2017-2035)
        8.1.2 Asia Pacific Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue by Type (2017-2035)
    8.2 Asia Pacific Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Market Size by Application
        8.2.1 Asia Pacific Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales by Application (2017-2035)
        8.2.2 Asia Pacific Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue by Application (2017-2035)
    8.3 Asia Pacific Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Market Size by Region
        8.3.1 Asia Pacific Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales by Region (2017-2035)
        8.3.2 Asia Pacific Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue by Region (2017-2035)
        8.3.3 China
        8.3.4 Japan
        8.3.5 South Korea
        8.3.6 India
        8.3.7 Australia
        8.3.8 Taiwan
        8.3.9 Indonesia
        8.3.10 Thailand
        8.3.11 Malaysia
        8.3.12 Philippines
9 Latin America
    9.1 Latin America Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Market Size by Type
        9.1.1 Latin America Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales by Type (2017-2035)
        9.1.2 Latin America Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue by Type (2017-2035)
    9.2 Latin America Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Market Size by Application
        9.2.1 Latin America Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales by Application (2017-2035)
        9.2.2 Latin America Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue by Application (2017-2035)
    9.3 Latin America Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Market Size by Country
        9.3.1 Latin America Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales by Country (2017-2035)
        9.3.2 Latin America Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue by Country (2017-2035)
        9.3.3 Mexico
        9.3.4 Brazil
        9.3.5 Argentina
10 Middle East and Africa
    10.1 Middle East and Africa Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Market Size by Type
        10.1.1 Middle East and Africa Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales by Type (2017-2035)
        10.1.2 Middle East and Africa Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue by Type (2017-2035)
    10.2 Middle East and Africa Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Market Size by Application
        10.2.1 Middle East and Africa Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales by Application (2017-2035)
        10.2.2 Middle East and Africa Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue by Application (2017-2035)
    10.3 Middle East and Africa Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Market Size by Country
        10.3.1 Middle East and Africa Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales by Country (2017-2035)
        10.3.2 Middle East and Africa Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue by Country (2017-2035)
        10.3.3 Turkey
        10.3.4 Saudi Arabia
11 Company Profiles
    11.1 Akebia
        11.1.1 Akebia Corporation Information
        11.1.2 Akebia Overview
        11.1.3 Akebia Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales, Price, Revenue and Gross Margin (2017-2022)
        11.1.4 Akebia Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Product Model Numbers, Pictures, Descriptions and Specifications
        11.1.5 Akebia Recent Developments
    11.2 Astellas
        11.2.1 Astellas Corporation Information
        11.2.2 Astellas Overview
        11.2.3 Astellas Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales, Price, Revenue and Gross Margin (2017-2022)
        11.2.4 Astellas Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Product Model Numbers, Pictures, Descriptions and Specifications
        11.2.5 Astellas Recent Developments
    11.3 Takeda
        11.3.1 Takeda Corporation Information
        11.3.2 Takeda Overview
        11.3.3 Takeda Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales, Price, Revenue and Gross Margin (2017-2022)
        11.3.4 Takeda Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Product Model Numbers, Pictures, Descriptions and Specifications
        11.3.5 Takeda Recent Developments
    11.4 Vifor
        11.4.1 Vifor Corporation Information
        11.4.2 Vifor Overview
        11.4.3 Vifor Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales, Price, Revenue and Gross Margin (2017-2022)
        11.4.4 Vifor Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Product Model Numbers, Pictures, Descriptions and Specifications
        11.4.5 Vifor Recent Developments
    11.5 Abbvie
        11.5.1 Abbvie Corporation Information
        11.5.2 Abbvie Overview
        11.5.3 Abbvie Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales, Price, Revenue and Gross Margin (2017-2022)
        11.5.4 Abbvie Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Product Model Numbers, Pictures, Descriptions and Specifications
        11.5.5 Abbvie Recent Developments
    11.6 Fresenius
        11.6.1 Fresenius Corporation Information
        11.6.2 Fresenius Overview
        11.6.3 Fresenius Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales, Price, Revenue and Gross Margin (2017-2022)
        11.6.4 Fresenius Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Product Model Numbers, Pictures, Descriptions and Specifications
        11.6.5 Fresenius Recent Developments
    11.7 Abbott
        11.7.1 Abbott Corporation Information
        11.7.2 Abbott Overview
        11.7.3 Abbott Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales, Price, Revenue and Gross Margin (2017-2022)
        11.7.4 Abbott Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Product Model Numbers, Pictures, Descriptions and Specifications
        11.7.5 Abbott Recent Developments
    11.8 Novadiol
        11.8.1 Novadiol Corporation Information
        11.8.2 Novadiol Overview
        11.8.3 Novadiol Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales, Price, Revenue and Gross Margin (2017-2022)
        11.8.4 Novadiol Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Product Model Numbers, Pictures, Descriptions and Specifications
        11.8.5 Novadiol Recent Developments
    11.9 Japan Tobacco Company
        11.9.1 Japan Tobacco Company Corporation Information
        11.9.2 Japan Tobacco Company Overview
        11.9.3 Japan Tobacco Company Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales, Price, Revenue and Gross Margin (2017-2022)
        11.9.4 Japan Tobacco Company Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Product Model Numbers, Pictures, Descriptions and Specifications
        11.9.5 Japan Tobacco Company Recent Developments
    11.10 Daiichi-Sankyo
        11.10.1 Daiichi-Sankyo Corporation Information
        11.10.2 Daiichi-Sankyo Overview
        11.10.3 Daiichi-Sankyo Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales, Price, Revenue and Gross Margin (2017-2022)
        11.10.4 Daiichi-Sankyo Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Product Model Numbers, Pictures, Descriptions and Specifications
        11.10.5 Daiichi-Sankyo Recent Developments
    11.11 Shield
        11.11.1 Shield Corporation Information
        11.11.2 Shield Overview
        11.11.3 Shield Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales, Price, Revenue and Gross Margin (2017-2022)
        11.11.4 Shield Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Product Model Numbers, Pictures, Descriptions and Specifications
        11.11.5 Shield Recent Developments
    11.12 Spectrum
        11.12.1 Spectrum Corporation Information
        11.12.2 Spectrum Overview
        11.12.3 Spectrum Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales, Price, Revenue and Gross Margin (2017-2022)
        11.12.4 Spectrum Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Product Model Numbers, Pictures, Descriptions and Specifications
        11.12.5 Spectrum Recent Developments
    11.13 OPKO
        11.13.1 OPKO Corporation Information
        11.13.2 OPKO Overview
        11.13.3 OPKO Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales, Price, Revenue and Gross Margin (2017-2022)
        11.13.4 OPKO Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Product Model Numbers, Pictures, Descriptions and Specifications
        11.13.5 OPKO Recent Developments
    11.14 Ardelyx
        11.14.1 Ardelyx Corporation Information
        11.14.2 Ardelyx Overview
        11.14.3 Ardelyx Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales, Price, Revenue and Gross Margin (2017-2022)
        11.14.4 Ardelyx Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Product Model Numbers, Pictures, Descriptions and Specifications
        11.14.5 Ardelyx Recent Developments
    11.15 Sanofi Genzyme
        11.15.1 Sanofi Genzyme Corporation Information
        11.15.2 Sanofi Genzyme Overview
        11.15.3 Sanofi Genzyme Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales, Price, Revenue and Gross Margin (2017-2022)
        11.15.4 Sanofi Genzyme Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Product Model Numbers, Pictures, Descriptions and Specifications
        11.15.5 Sanofi Genzyme Recent Developments
    11.16 Amgen
        11.16.1 Amgen Corporation Information
        11.16.2 Amgen Overview
        11.16.3 Amgen Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales, Price, Revenue and Gross Margin (2017-2022)
        11.16.4 Amgen Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Product Model Numbers, Pictures, Descriptions and Specifications
        11.16.5 Amgen Recent Developments
12 Industry Chain and Sales Channels Analysis
    12.1 Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Industry Chain Analysis
    12.2 Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Key Raw Materials
        12.2.1 Key Raw Materials
        12.2.2 Raw Materials Key Suppliers
    12.3 Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Production Mode & Process
    12.4 Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales and Marketing
        12.4.1 Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales Channels
        12.4.2 Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Distributors
    12.5 Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
    13.1 Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Industry Trends
    13.2 Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Market Drivers
    13.3 Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Market Challenges
    13.4 Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Market Restraints
14 Key Findings in The Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Study
15 Appendix
    15.1 Research Methodology
        15.1.1 Methodology/Research Approach
        15.1.2 Data Source
    15.2 Author Details
    15.3 Disclaimer                        

Research Methodology

Data collection and base year analysis are done using proprietary data collection modules with large sample sizes. The process includes obtaining market information through extensive secondary sources, paid databases, and verifying data via primary (industry expert) validation.

Our market models include Vendor Positioning Grids, Market Timeline Analysis, Company Market Share Analysis, and Top-Down/Bottom-Up forecasting models. To know more about the research methodology, drop an inquiry to speak to our industry experts.

Speak to Analyst

Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Market